Chemosensory scientists have been skeptical that reports of COVID-19 taste loss are
genuine, in part because before COVID-19 taste loss was rare and often confused with smell …

Objective To clarify in patients with covid-19 the recovery rate of smell and taste, proportion
with persistent dysfunction of smell and taste, and prognostic factors associated with …

Olfactory dysfunction (OD) is one of the important and difficult-to-treat symptoms of
eosinophilic chronic rhinosinusitis (CRS), which is typically associated with type 2 …

Background and purpose The coronavirus disease 2019 (COVID-19) has been associated
with olfactory dysfunction. The persistent symptoms of anosmia or hyposmia were …

Background and purpose Clinical outcomes of multiple sclerosis (MS) patients affected by
coronavirus disease 2019 (COVID‐19) have been thoroughly investigated, but a further …

Background There is evidence that chemosensory dysfunctions, including smell and taste
disorders, are common findings in patients with SARS-CoV-2 infection. However, the …

Purpose Olfactory dysfunction (OD) is a common presenting sign of coronavirus-19 (COVID-
19) infection and remains persistent in up to 7% of patients one year after diagnosis …

The association of anosmia/ageusia with a positive severe respiratory syndrome
coronavirus 2 (SARS-CoV-2) test is well-established, suggesting these symptoms are …

Although COVID-19 vaccines exhibit diverse side effects, taste and saliva secretory
disorders have remained poorly understood despite their negative impact on the overall …

Transmission of SARS-CoV-2 without symptoms is well described, and may be mitigated by
mass testing. Nonetheless, the optimal implementation and quantitative real-world impact of …